Powered by MOMENTUM MEDIA
lawyers weekly logo
Advertisement
Superannuation
04 July 2025 by Maja Garaca Djurdjevic

From reflection to resilience: How AMP Super transformed its investment strategy

AMP’s strong 2024–25 returns were anything but a fluke – they were the product of a carefully recalibrated investment strategy that began several ...
icon

Regulator investigating role of super trustees in Shield and First Guardian failures

ASIC is “considering what options” it has to hold super trustees to account for including the failed schemes on their ...

icon

Magellan approaches $40bn, but performance fees decline

Magellan has closed out the financial year with funds under management of $39.6 billion. Over the last 12 months, ...

icon

RBA poised for another rate cut in July, but decision remains on a knife’s edge

Economists from the big four banks have all predicted the RBA to deliver another rate cut during its July meeting, ...

icon

Retail super funds deliver double-digit returns despite market turbulence

Retail superannuation funds Vanguard Super and Colonial First State have posted robust double-digit returns for ...

icon

Markets climb ‘wall of worry’ to fuel strong super returns, but can the rally last?

Australian super funds notched a third consecutive year of strong returns, with the median balanced option delivering an ...

VIEW ALL

GMO, UBS staff defections take mandate toll

  •  
By
  •  
2 minute read

Health fund MBF's financial division, ClearView Retirement Solutions, has dumped GMO Australia and UBS Global Asset Management (UBSGAM) from its Australian shares portfolio.

Health fund MBF's financial division, ClearView Retirement Solutions, has dumped GMO Australia and UBS Global Asset Management (UBSGAM) from its Australian shares portfolio.

ClearView has hired quant manager Dimensional Fund Advisers in their place.

GMO and UBSGAM managed $92 million and $162 million respectively. Dimensional Fund Advisers will manage $190 million.

ClearView's decision to replace UBSGAM and GMO comes at a bad time for both managers, which have lost a series of key staff this year to boutiques.

Former UBSGAM head of Australian equities Paul Fiani left in early 2007 to form his own boutique, Integrity Investment Management. He took portfolio manager Shawn Burns, head of research John Moran and investment analyst Marcus Truman with him.

The manager also lost a $320 million Australian equities mandate with Victorian Funds Management Corporation in September.

GMO lost head of Australian equities Max Cappetta and head of equities research Anthony Corr in September. They left to jointly establish quant boutique Continuum Capital Management with former colleague Brett McElwee.

The manager has lost a series of investment mandates as a result.

ClearView, which is advised by Intech, manages over $2 billion.